Originally Posted by
Ollie Onion
The normal approval time frame is only that long because of 2 factors:
1 - Funding, it takes a lot of time to raise the billions required for a 3 stage approval
2 - Disease! You need outbreaks of the disease that are big enough and consistent enough to actually run the trials. The MERs vaccine never progressed to approval as by the time they were ready for trials the disease had killed itself off.
With Covid we had both, the funding was enormous and plentiful, the disease was everywhere, no shortage of people to participate in the trials, no steps were skips or shortcut.
Pretending otherwise is scaremongering just like your selective quoting. These RNA vaccines were under development for years with the biggest area of research being the vaccination and treatment of Cancer, the most promising of these had stalled as they needed to raise over $3bn for the trial stages, thankfully Covid had super accelerated this area and we have just seen the first mRNA vaccine for Melanoma enter its last stage trials. I assume you will also be reluctant to take advantage of the cancer saving vaccines developed as a direct result of the Covid research and funding?
Seems you have not been keeping up with developments:
Press Conference: Dr. Aseem Malhotra’s New Peer-Reviewed Paper Calls for Immediate and “Complete Suspension” of Covid-19 Vaccine
“..The World Council for Health hosted a press conference in London on September 27, 2022 featuring one of Britain’s most influential cardiologists:
Dr. Malhotra presented on his new peer-reviewed paper published in the Journal of Insulin Resistance
…real-world data reveals that in the non-elderly population the number needed to vaccinate to prevent one death from Covid-19 runs into thousands and that re-analysis of randomized controlled trial data suggests a greater risk of suffering a serious adverse event from the vaccine than to be hospitalized with Covid-19.
Dr Aseem Malhotra is an award-winning Consultant Cardiologist, Fellow of the Royal College of Physicians, and President of the Scientific Advisory Committee – The Public Health Collaboration. Dr. Malhotra is an internationally renowned expert in the prevention, diagnosis and management of heart disease. His areas of expertise include evidence based medicine and collaborative shared decision-making with patients. Aseem Malhotra is also an honorary council member to the Metabolic Psychiatry Clinic at Stanford University school of medicine California..”
https://worldcouncilforhealth.org/mu...ss-conference/